Search Within

Jan Philipp Bewersdorf

Formats
  1. Meeting Abstract (40)
  2. Journal Article (26)
  3. Review (21)
  4. Research Letter (7)
  5. Editorial (4)
  6. Correspondence (3)
  7. Guidelines (1)
Groups
  1. GME, Medicine (102)
  2. Graduate Medical Education (102)
  3. Hematology-Oncology Fellows (102)
  4. Center for Hematologic Malignancies (59)
  5. Department of Medicine (59)
  6. Hematologic Malignancies, Division of (59)

More Groups

People
  1. Eytan Stein (33)
  2. Aaron Goldberg (19)
  3. Omar Abdel-Wahab (15)
  4. Andriy Derkach (14)
  5. Raajit Rampal (9)
  6. Maximilian Stahl (5)

More People

Years
  1. 2025 (6)
  2. 2024 (26)
  3. 2023 (42)
  4. 2022 (25)
  5. 2021 (3)
Publications
  1. Blood (41)
  2. Leukemia and Lymphoma (7)
  3. Leukemia (6)
  4. Blood Reviews (5)
  5. Journal of Clinical Oncology (4)
  6. American Journal of Hematology (3)

More Publications

Publishers
  1. American Society of Hematology (43)
  2. Nature Publishing Group (8)
  3. Taylor & Francis Group (8)
  4. American Society of Clinical Oncology (5)
  5. Churchill Livingstone (5)
  6. Elsevier Inc. (4)

More Publishers

Results (102)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemias
    Journal Article

    Kim, W. J.; Crosse, E. I.; De Neef, E.; Etxeberria, I.; Sabio, E. Y.; Wang, E.; Bewersdorf, J. P.; Lin, K. T.; Lu, S. X.; Belleville, A.; more...
    Cell (2025)

    Fulltext@MSK | Save
  • A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies
    Journal Article

    Mosialou, I.; Ali, A. M.; Labella, R.; Bisikirska, B.; Cuesta-Dominguez, A.; Vgenopoulou, P.; Reyes, I.; Rao, S. M.; Wang, A.; Luo, N.; more...
    Cancer Cell (2025)

    Fulltext@MSK | Save
  • Venetoclax–azacitidine versus azacitidine for the treatment of primary refractory or first relapsed acute myeloid leukemia. An IPC-DATAML-MSKCC retrospective study
    Correspondence

    Petit, C.; Higue, J.; Acheaibi, Z.; Gilhodes, J.; Hospital, M. A.; Devillier, R.; Bewersdorf, J.; Goldberg, A. D.; Pigneux, A.; Vey, N.; more...
    American Journal of Hematology (2025)

    Fulltext@MSK | Save
  • Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies
    Research Letter

    Bewersdorf, J. P.; Mi, X.; Lu, B.; Kuykendall, A.; Sallman, D.; Patel, M.; Stevens, D.; Philipovskiy, A.; Sutamtewagul, G.; Masarova, L.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Analyzing determinants of premature trial discontinuation in leukemia clinical trials
    Journal Article

    Rotter, L. K.; Alhajahjeh, A.; Stempel, J. M.; Grimshaw, A. A.; Bewersdorf, J. P.; Blaha, O.; Kewan, T.; Podoltsev, N. A.; Shallis, R. M.; Mendez, L.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Pacritinib response is associated with overall survival in myelofibrosis: PERSIST-2 landmark analysis of survival
    Journal Article

    Ajufo, H.; Bewersdorf, J. P.; Harrison, C.; Palandri, F.; Mascarenhas, J.; Palmer, J.; Gerds, A.; Kiladjian, J. J.; Buckley, S.; Derkach, A.; more...
    European Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Validation of recent response criteria (ELN-22, IWG-23 and PB-CR) in 1634 MDS/CMML/AML patients treated with HMA or HMA-VEN using CPH models and a CPH deep neural network - Can or should response criteria be harmonized for similarly treated patients?
    Meeting Abstract

    Pleyer, L.; Vaisband, M.; Klammer, P.; Drost, M.; Angermann, H.; Keil, F.; Petzer, V.; Heibl, S.; Moritz, J.; Girschikofsky, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Clinical outcomes and variability based on baseline cytogenetic risk of patients with MDS treated with hypomethylating agents: An analysis from the International Consortium for MDS (icMDS) validate database
    Meeting Abstract

    Getz, T. M.; Kewan, T.; Bewersdorf, J. P.; Stempel, J. M.; Lanino, L.; Wei, W.; Ali, N. H. A.; Dezern, A. E.; Sekeres, M. A.; Uy, G. L.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Artificial-intelligence, data-driven, comprehensive classification of myeloid neoplasms based on genomic, morphological and histological features
    Meeting Abstract

    Lanino, L.; D'Amico, S.; Maggioni, G.; Ali, N. H. A.; Wang, Y. H.; Gurnari, C.; Gagelmann, N.; Bewersdorf, J. P.; Ball, S.; Guglielmelli, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of response to hypomethylating agent-based therapy on survival outcomes in the context of baseline clinical-molecular risk and transplant status in patients with myelodysplastic syndromes/neoplasms (MDS): An analysis from the international consortium for MDS (icMDS) validate database
    Meeting Abstract

    Rolles, B.; Bewersdorf, J. P.; Kewan, T.; Blaha, O.; Stempel, J. M.; Lanino, L.; Al Ali, N. H.; DeZern, A. E.; Sekeres, M. A.; Uy, G. L.; more...
    Blood (2024)

    Fulltext@MSK | Save